IMNM

Immunome Inc

$21.41

0.22 (1.04%) Today

— up— down

Compare IMNM

Market Cap

$2.40B+153.2%

Revenue (TTM)

$4.02M-63.3%

Net Income (TTM)

$-267,745,650

EPS (TTM)

-2.36

Shares Out

113.25M

Open

$20.65

Previous Close

$21.19

Day Range

$20.65 – $21.87

52-Week Range

$7.96 – $27.65

Beta

2.08

Volume

934.99K

Avg Volume

1.30M

Analyst Rating

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

About IMNM

The immunome is the set of genes that code for proteins which constitute the immune system, excluding those that are widespread in other cell types, and not involved in the immune response itself. It is further defined as the set of peptides derived from the proteome that interact with the immune system. There are numerous ongoing efforts to characterize and sequence the immunomes of humans, mice, and elements of non-human primates. Typically, immunomes are studied using immunofluorescence microscopy to determine the presence and activity of immune-related enzymes and pathways. Practical applications for studying the immunome include vaccines, therapeutic proteins, and further treatment of other diseases. The study of the immunome falls under the field of immunomics.